Oncology

VA Educates Patients about Who Really Needs Testosterone Therapy

VA Educates Patients about Who Really Needs Testosterone Therapy

COLUMBIA, MO – Often spurred by advertising touting the benefits of testosterone supplementation for “low T,” veterans treated by the VA increasingly are requesting the replacement therapy.

VA Study Finds That Statins Reduce Prostate Cancer Recurrence Risk

VA Study Finds That Statins Reduce Prostate Cancer Recurrence Risk

CHAPEL HILL, NC – Physicians commonly recommend statins for veterans with high triglyceride levels.

No Higher Breast Cancer Rates Among Transgender Veterans

JOHNSON CITY, TN – Consistent with past European studies, new research from the Mountain Home VAMC suggests that transgender (TG) veterans have no higher rates of breast cancer than others. The study, published recently in the journal Breast Cancer Research… Read More

Biology Blamed for Later-Stage Breast Cancer in Black Women

SAN DIEGO – African-American women present with more aggressive breast tumors and at later stages than white women. Many factors have been proposed to explain these findings, including socioeconomic status, cultural beliefs and access to medical care. A new military… Read More

More Breast Cancer Patients Opt for Mastectomy Than Previously

NASHVILLE – Many more breast cancer patients now opt for mastectomy, including removal of both breasts, instead of choosing breast conservation surgery (BCS), even with early-stage disease confined to one breast, according to a new study. The rates of increase… Read More

VA Tackles Obesity Paradox:

VA Tackles Obesity Paradox:

Why Do Overweight Patients Live Longer with Heart Failure?
Now the leading cause of hospital admissions in the VA Health Care System, heart failure is associated with high mortality rates and poor quality of life.

December 2014 Focus

In this Issue: Focus on HIV-HCV New Treatments Offer More Options, Fewer Side Effects for HIV-Infected Veterans Despite High Costs, VA Makes Sure Veterans Have Access to Newest HCV Drugs Pharmacy Update Partnerships, Drive-Throughs Seek to Increase Veterans’ Flu Immunization… Read More

November 2014 Focus

In this Issue: Focus on Oncology Increasing Cancer Treatment Delays Have Plagued VAMCs for Nearly a Decade Male Breast Cancer at the VA Rarer Than the Female Disease, but More Deadly Pharmacy Update Training Program Prepares Military Pharmacy Techs for… Read More

Another Expansion of Approved Use for Cyramza

INDIANAPOLIS – The approved use of Cyramza (ramucirumab) has been expanded to treat patients with metastatic non-small cell lung cancer (NSCLC). Cyramza, marketed by Eli Lilly, blocks the blood supply that fuels tumor growth. The drug is approved for patients… Read More

New Option for Unresectable, Metastatic Melanoma Gets Approval

PRINCETON, NJ – Accelerated approval has been granted by the Food and Drug Administration to Opdivo (nivolumab), a new treatment for patients with unresectable or metastatic melanoma who no longer respond to other drugs. Opdivo, marketed by Bristol-Myers Squibb, works… Read More

New Weight Management Treatment Approved

PLAINSBORO, NJ – The Food and Drug Administration has approved a new treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. Saxenda (liraglutide [rDNA origin] injection) is approved for use in adults with a… Read More

Murtha Center, USU Join NCI to Battle Common Foe: Cancer

Murtha Center, USU Join NCI to Battle Common Foe: Cancer

Alliance Research Not Limited by Private-Sector Restraints By Annette M. Boyle  BETHESDA, MD – In celebration of its second anniversary, the John P. Murtha Cancer Center at the Walter Reed National Military Medical Center, announced plans to substantially expand its… Read More

Agent Orange-Related Non-Melanotic Skin Cancer Still Affects Veterans

HOUSTON – Decades later, exposure to Agent Orange puts Vietnam War veterans at high risk for certain types of skin cancer. That’s according to a report published earlier this year in Find Your Surgeon Plastic and Reconstructive Surgery, the official… Read More

Skin Cancer Risk High During Deployment

NASHVILLE – Military personnel deployed abroad in climates such as Afghanistan and Iraq have increased risk factors for skin cancer, according to a new study. The increased risk is especially present when servicemembers serve in tropical and sunny climates, according… Read More

October 2014 Focus

In this Issue: Focus on Oncology Increasing Cancer Treatment Delays Have Plagued VAMCs for Nearly a Decade Male Breast Cancer at the VA Rarer Than the Female Disease, but More Deadly Pharmacy Update Training Program Prepares Military Pharmacy Techs for… Read More

September 2014 Focus

In this Issue: Focus on Pain Telecare Program Effectively Manages Pain, Reduces Opioid Use in VA Patients Research Finds Unexpectedly High Rates of Pain, Opioid Use in Recently Deployed Soldiers Pharmacy Update Statins Reduce Barrett‘s Esophagus; Cancer Precursor Affects About… Read More

Computer Model: HCV, Associated Cancer Will Be Rare by 2036

Computer Model: HCV, Associated Cancer Will Be Rare by 2036

By Brenda L. Mooney PITTSBURGH – Will hepatitis C become a rare disease over the next two decades or so? The answer is yes, according to a computer simulation conducted by the University of Pittsburgh Graduate School of Public Health… Read More

VA, DoD Remain on Front Lines in Ongoing War Against Cancer

VA, DoD Remain on Front Lines in Ongoing War Against Cancer

FORT LEWIS-MCCHORD, WA – The DoD’s leadership in cancer research started accidentally, but funding from Congress has ensured that both the Army and VA have remained on the front lines in the war on cancer during the past 50 years.

VA Proposes Physician Pay Increases, Begins Major Recruiting Campaign

VA Proposes Physician Pay Increases, Begins Major Recruiting Campaign

By Sandra Basu WASHINGTON – The maximum rates of annual pay for incoming VHA physicians and dentists would be increased as much as $35,000, under a VA proposal announced last month. The updated pay tables would allow physicians and dentists… Read More

Male Breast Cancer at the VA Much Rarer Than the Female Disease, but More Deadly

Male Breast Cancer at the VA Much Rarer Than the Female Disease, but More Deadly

Annette M. Boyle WASHINGTON – Men are diagnosed with less than 0.1% of all breast cancers, but for those unfortunate few, the disease extracts a high toll — and a 65% increase in mortality risk compared to women. The interpretation… Read More